トップページ  >  EVENTS  >  詳細

2024/07/05

第51回日本毒性学会学術年会

2024/05/14

2024年2月14日（水）における次世代ゼブラフィッシュ創薬・研究開発セミナー

2024/05/08

第51回日本毒性学会ゼブラフィッシュ腎毒性スクリーニング

2024/05/02

ゼブラフィッシュ毒性研究における飼育品質管理の重要性

2024/05/01

high-throughput individual zebrafish screening

2024/04/26

ゼブラフィッシュ創薬の長所と課題

2024/04/25

discovery of stanniocalcin1 as cardiotoxic defence gene

2024/04/24

Tumour Angiogenesis in Patient-Deriveved Xenograft Zebarafish Model

2024/04/23

Aging-associated microstructural deterioration of vertebra in zebra fi sh

2024/04/23

Aging-associated microstructural deterioration of vertebra in zebra fi sh

一覧に戻る

Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening

2021/10/13

---

BioJapan2021: Oct 13-15, 2021
We developed novel zebrafish model for patient-derived xenograft (PDXZ), and demonstrated that PDXZ has high rate and speed of engraftment in normal zebrafish when the immune system is immature, requires less than 100 cancer cells for transplantation, and can be quantitatively analyzed in 2 days. We report on drug efficacy screening system that can be quantitatively analyzed within a week.

関連リンク

三重大学大学院医学系研究科システムズ薬理学

biojapan2021

関連ファイル

Patient-Derived Cancer Xenograft Zebrafish Model (PDXZ) for Quantitative Drug Discovery Screening